Salidroside and the HPA Axis: Stress Resilience and Cortisol Regulation

Stress is an unavoidable feature of human life. Although acute stress responses can be adaptive and essential for survival, chronic psychological and physiological stress can have profound negative effects on our health. Persistent activation of the hypothalamic-pituitary-adrenal (HPA) axis, the body’s primary neuroendocrine stress-response system, has been linked to anxiety, depression, fatigue, cognitive impairment, metabolic dysfunction, cardiovascular disease, and accelerated biological aging [1–5].

Adaptogens are substances that enhance the body’s ability to resist physical, chemical, and biological stressors while promoting physiological balance [6]. As interest in adaptogenic compounds continues to grow, salidroside has emerged as one of the most promising natural molecules for supporting stress resilience. Salidroside is a phenolic glycoside isolated primarily from Rhodiola rosea, an adaptogenic herb traditionally used in Tibetan, Scandinavian, Russian, and Chinese medicine to combat fatigue and enhance physical and mental performance under stressful conditions [7–9].

A growing body of experimental evidence suggests that salidroside may help regulate HPA axis activity, normalize cortisol responses, protect against stress-induced neuronal damage, and improve resilience to both psychological and physiological stressors. Although much of the research remains preclinical, the findings provide important insights into the mechanisms through which salidroside may influence stress biology.

This article looks at the relationship between salidroside and the HPA axis, examining how this compound may support healthy cortisol regulation and improve the body’s ability to adapt to stress.

What is the HPA Axis?

The HPA axis serves as the central coordinator of the body’s stress response.

When a stressor is perceived, neurons in the hypothalamus release corticotropin-releasing hormone (CRH). CRH stimulates the anterior pituitary gland to secrete adrenocorticotropic hormone (ACTH), which then travels through the bloodstream to the adrenal glands. In response, the adrenal cortex releases glucocorticoids, primarily cortisol in humans [10].

Cortisol performs numerous functions that help the body cope with stress:

• Mobilization of glucose and energy stores
• Regulation of immune activity
• Modulation of inflammation
• Enhancement of cardiovascular function
• Alteration of memory and cognition
• Coordination of behavioral responses

Under normal conditions, cortisol release is tightly controlled through negative feedback mechanisms. Elevated cortisol signals the hypothalamus and pituitary gland to reduce further CRH and ACTH secretion, thereby restoring balance (homeostasis). However, chronic stress can disrupt this feedback loop. Sustained cortisol elevation may lead to glucocorticoid receptor dysfunction, impaired feedback sensitivity, and long-term dysregulation of HPA axis activity [11]. Such alterations have been observed in conditions including major depressive disorder, chronic fatigue syndrome, burnout, post-traumatic stress disorder (PTSD), and anxiety disorders.

Because HPA-axis dysregulation is implicated in numerous stress-related conditions, compounds capable of restoring healthy neuroendocrine regulation have attracted considerable scientific interest.

Salidroside and Cortisol Regulation

One of the most intriguing aspects of salidroside research is its apparent ability to modulate cortisol responses to stress.

Animal studies consistently show that salidroside can attenuate excessive activation of the HPA axis during periods of chronic stress.

For instance, rodents exposed to chronic unpredictable stress typically develop elevated corticosterone levels - the rodent equivalent of cortisol — along with behavioral changes resembling anxiety and depression. Administration of salidroside has been shown to reduce corticosterone concentrations while improving behavioral outcomes in several experimental models [12–14].

In these studies, salidroside appears to normalize rather than completely suppress glucocorticoid production. This distinction is important because cortisol remains essential for healthy physiological function. The goal is not elimination of cortisol but restoration of an appropriate stress response.

Neuroprotection Against Stress-Induced Damage

Excessive cortisol exposure can negatively affect brain structures involved in mood regulation, cognition, and stress adaptation [15–17].

The hippocampus is a particularly vulnerable brain region. It contains a high density of glucocorticoid receptors and plays a critical role in HPA-axis feedback control. Chronic stress may contribute to hippocampal atrophy, impaired neurogenesis, and cognitive dysfunction [18].

Salidroside has demonstrated robust neuroprotective effects in experimental studies, with research indicating it can reduce neuronal apoptosis, preserve hippocampal structure, increase neuronal survival [19], enhance synaptic plasticity, promote neurogenesis, and improve learning and memory performance.

By protecting stress-sensitive brain regions, salidroside may help preserve the neural circuitry responsible for healthy stress adaptation. You can read more on salidroside and neuroprotection here.

Influence on Oxidative Stress and Inflammation

The physiological consequences of chronic stress extend far beyond cortisol itself.

Persistent activation of the HPA-axis increases the production of reactive oxygen species and pro-inflammatory cytokines throughout the body. Oxidative stress and inflammation are increasingly recognized as major contributors to the development of stress-related diseases [20,21].

Salidroside possesses potent antioxidant and anti-inflammatory properties that offer potential in addressing these contributors [22–24].

Experimental studies demonstrate that salidroside can:

• Increase superoxide dismutase activity
• Enhance glutathione defenses
• Reduce lipid peroxidation
• Suppress NF-κB signaling [22]
• Lower inflammatory cytokine production
• Protect mitochondrial function

Human Evidence and Current Limitations

While the mechanistic evidence supporting salidroside is extensive, direct human research remains relatively limited.

Several clinical studies involving Rhodiola rosea extracts have reported improvements in:

• Stress-related fatigue
• Mental performance
• Burnout symptoms
• Anxiety scores
• Mood disturbances

Some trials have also observed reductions in subjective stress and improvements in resilience-related outcomes [25]. However, most studies have investigated whole Rhodiola extracts rather than isolated salidroside. As a result, determining the precise contribution of salidroside remains challenging.

Furthermore, relatively few human studies have directly measured cortisol responses or HPA-axis biomarkers following salidroside supplementation.

Future randomized controlled trials examining cortisol dynamics, ACTH responses, glucocorticoid receptor activity, and stress resilience outcomes will be necessary to fully establish salidroside’s role in human HPA-axis regulation.

Conclusion

The HPA axis serves as the body’s central stress-response network, coordinating hormonal, neurological, metabolic, and immune adaptations to stress. Chronic activation of this system can contribute to numerous physical and psychological disorders through sustained cortisol elevation, inflammation, oxidative stress, and impaired neuroplasticity.

Salidroside, a key bioactive compound found in Rhodiola rosea, has demonstrated considerable potential as a modulator of stress physiology. Experimental research suggests that salidroside may normalize cortisol responses, improve glucocorticoid feedback regulation, reduce CRH and ACTH signaling, protect stress-sensitive brain regions, support neurotransmitter balance, and mitigate inflammation and oxidative damage.

Although human evidence remains limited, the existing data support the traditional reputation of salidroside as an adaptogenic compound that enhances resilience under physical and psychological stress. As research continues to evolve, salidroside may emerge as an increasingly important tool for supporting healthy stress adaptation and maintaining neuroendocrine balance in an increasingly stressful world.

 

References

[1]         C. Faravelli, Childhood stressful events, HPA axis and anxiety disorders, WJP 2 (2012) 13. https://doi.org/10.5498/wjp.v2.i1.13.

[2]         A.G. Bertollo, C.F. Santos, M.D. Bagatini, Z.M. Ignácio, Hypothalamus-pituitary-adrenal and gut-brain axes in biological interaction pathway of the depression, Front. Neurosci. 19 (2025) 1541075. https://doi.org/10.3389/fnins.2025.1541075.

[3]         J.A.M.J.L. Janssen, New Insights into the Role of Insulin and Hypothalamic-Pituitary-Adrenal (HPA) Axis in the Metabolic Syndrome, IJMS 23 (2022) 8178. https://doi.org/10.3390/ijms23158178.

[4]         A.E. Gaffey, C.S. Bergeman, L.A. Clark, M.M. Wirth, Aging and the HPA axis: Stress and resilience in older adults, Neuroscience & Biobehavioral Reviews 68 (2016) 928–945. https://doi.org/10.1016/j.neubiorev.2016.05.036.

[5]         J. Jokinen, P. Nordström, HPA axis hyperactivity and cardiovascular mortality in mood disorder inpatients, Journal of Affective Disorders 116 (2009) 88–92. https://doi.org/10.1016/j.jad.2008.10.025.

[6]         A. Panossian, Understanding adaptogenic activity: specificity of the pharmacological action of adaptogens and other phytochemicals, Annals of the New York Academy of Sciences 1401 (2017) 49–64. https://doi.org/10.1111/nyas.13399.

[7]         K. Liang, S. Ma, K. Luo, R. Wang, C. Xiao, X. Zhang, Y. Gao, M. Li, Salidroside: An Overview of Its Promising Potential and Diverse Applications, Pharmaceuticals 17 (2024) 1703. https://doi.org/10.3390/ph17121703.

[8]         S. He, H. Fan, B. Sun, M. Yang, H. Liu, J. Yang, J. Liu, S. Luo, Z. Chen, J. Zhou, L. Xia, S. Zhang, B. Yan, Tibetan medicine salidroside improves host anti-mycobacterial response by boosting inflammatory cytokine production in zebrafish, Front. Pharmacol. 13 (2022) 936295. https://doi.org/10.3389/fphar.2022.936295.

[9]         X. Li, W. Chen, J. Simal-Gandara, M.I. Georgiev, H. Li, H. Hu, X. Wu, T. Efferth, S. Wang, West meets east: open up a dialogue on phytomedicine, Chin Med 16 (2021) 57. https://doi.org/10.1186/s13020-021-00467-6.

[10]       J.P. Herman, J.M. McKlveen, S. Ghosal, B. Kopp, A. Wulsin, R. Makinson, J. Scheimann, B. Myers, Regulation of the Hypothalamic‐Pituitary‐Adrenocortical Stress Response, in: Y.S. Prakash (Ed.), Comprehensive Physiology, 1st ed., Wiley, 2016: pp. 603–621. https://doi.org/10.1002/cphy.c150015.

[11]       S.G. Nunez, S.P. Rabelo, N. Subotic, J.W. Caruso, N.N. Knezevic, Chronic Stress and Autoimmunity: The Role of HPA Axis and Cortisol Dysregulation, IJMS 26 (2025) 9994. https://doi.org/10.3390/ijms26209994.

[12]       C. Cifani, M.V. Micioni Di B., G. Vitale, V. Ruggieri, R. Ciccocioppo, M. Massi, Effect of salidroside, active principle of Rhodiola rosea extract, on binge eating, Physiology & Behavior 101 (2010) 555–562. https://doi.org/10.1016/j.physbeh.2010.09.006.

[13]       A. Dinel, I. Guinobert, C. Lucas, C. Blondeau, V. Bardot, I. Ripoche, L. Berthomier, V. Pallet, S. Layé, C. Joffre, Reduction of acute mild stress corticosterone response and changes in stress‐responsive gene expression in male Balb/c mice after repeated administration of a Rhodiola rosea L. root extract, Food Science & Nutrition 7 (2019) 3827–3841. https://doi.org/10.1002/fsn3.1249.

[14]       S.-J. Yang, H.-Y. Yu, D.-Y. Kang, Z.-Q. Ma, R. Qu, Q. Fu, S.-P. Ma, Antidepressant-like effects of salidroside on olfactory bulbectomy-induced pro-inflammatory cytokine production and hyperactivity of HPA axis in rats, Pharmacology Biochemistry and Behavior 124 (2014) 451–457. https://doi.org/10.1016/j.pbb.2014.07.015.

[15]       J.N.D. Souza-Talarico, M.-F. Marin, S. Sindi, S.J. Lupien, Effects of stress hormones on the brain and cognition: Evidence from normal to pathological aging, Dement. Neuropsychol. 5 (2011) 8–16. https://doi.org/10.1590/S1980-57642011DN05010003.

[16]       Y. Chen, J. Zhang, H. Tan, J. Li, Y. Yu, Detrimental effects of hypercortisolism on brain structure and related risk factors, Sci Rep 10 (2020) 12708. https://doi.org/10.1038/s41598-020-68166-0.

[17]       A. Sic, K. Cvetkovic, E. Manchanda, N.N. Knezevic, Neurobiological Implications of Chronic Stress and Metabolic Dysregulation in Inflammatory Bowel Diseases, Diseases 12 (2024) 220. https://doi.org/10.3390/diseases12090220.

[18]       E.J. Kim, B. Pellman, J.J. Kim, Stress effects on the hippocampus: a critical review, Learn. Mem. 22 (2015) 411–416. https://doi.org/10.1101/lm.037291.114.

[19]       L. Zhu, Z. Liu, Y. Ren, X. Wu, Y. Liu, T. Wang, Y. Li, Y. Cong, Y. Guo, Neuroprotective effects of salidroside on ageing hippocampal neurons and naturally ageing mice via the PI3K /Akt/ TERT pathway, Phytotherapy Research 35 (2021) 5767–5780. https://doi.org/10.1002/ptr.7235.

[20]       G. Pizzino, N. Irrera, M. Cucinotta, G. Pallio, F. Mannino, V. Arcoraci, F. Squadrito, D. Altavilla, A. Bitto, Oxidative Stress: Harms and Benefits for Human Health, Oxidative Medicine and Cellular Longevity 2017 (2017) 8416763. https://doi.org/10.1155/2017/8416763.

[21]       Y.-Z. Liu, Y.-X. Wang, C.-L. Jiang, Inflammation: The Common Pathway of Stress-Related Diseases, Front. Hum. Neurosci. 11 (2017) 316. https://doi.org/10.3389/fnhum.2017.00316.

[22]       D. Li, Y. Fu, W. Zhang, G. Su, B. Liu, M. Guo, F. Li, D. Liang, Z. Liu, X. Zhang, Y. Cao, N. Zhang, Z. Yang, Salidroside attenuates inflammatory responses by suppressing nuclear factor-κB and mitogen activated protein kinases activation in lipopolysaccharide-induced mastitis in mice, Inflamm. Res. 62 (2013) 9–15. https://doi.org/10.1007/s00011-012-0545-4.

[23]       Z. Qi, S. Qi, L. Ling, J. Lv, Z. Feng, Salidroside attenuates inflammatory response via suppressing JAK2-STAT3 pathway activation and preventing STAT3 transfer into nucleus, International Immunopharmacology 35 (2016) 265–271. https://doi.org/10.1016/j.intimp.2016.04.004.

[24]       M.V.N.L. Chaitanya, D. Patle, S. Kumar Singh, A. Mazumder, R. Kumar Sindhu, K. Dua, N. Khurana, P. Arora, Salidroside and inflammation-linked disorders: integrative insights into the pharmacological effects and mechanistic targets, Inflammopharmacol 33 (2025) 5861–5887. https://doi.org/10.1007/s10787-025-01964-y.

[25]       E. Ivanova Stojcheva, J.C. Quintela, The Effectiveness of Rhodiola rosea L. Preparations in Alleviating Various Aspects of Life-Stress Symptoms and Stress-Induced Conditions—Encouraging Clinical Evidence, Molecules 27 (2022) 3902. https://doi.org/10.3390/molecules27123902.